This article has been indexed from Help Net Security
Crosspoint Capital Partners announced that it led a Series B investment in ReversingLabs (the “Company”), a provider of technology to protect software producers and enterprise software buyers against the threat of software supply chain attacks. Joining Crosspoint is existing investor ForgePoint Capital along with new investor Prelude, a Mercato Partners fund. Terms were not disclosed. With the rise in sophisticated software supply chain cyberattacks such as implants, ReversingLabs offers the ability to assess the integrity … More
The post Crosspoint invests in ReversingLabs to scale its sales and marketing efforts appeared first on Help Net Security.
Read the original article: Crosspoint invests in ReversingLabs to scale its sales and marketing efforts